Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

FDA grants fast track designation to Synlogic’s SYNB1020 synthetic biotic treatment

pharmaceutical-technologyJune 29, 2017

Tag: FDA , Synlogic’s SYNB1020 , biotic treatment

PharmaSources Customer Service